Provided by Tiger Trade Technology Pte. Ltd.

Jasper Therapeutics

0.5800
-0.0454-7.26%
Post-market: 0.5784-0.0016-0.28%19:59 EDT
Volume:540.20K
Turnover:328.52K
Market Cap:19.30M
PE:-0.62
High:0.6546
Open:0.6200
Low:0.5721
Close:0.6254
52wk High:2.69
52wk Low:0.3151
Shares:33.27M
Float Shares:30.00M
Volume Ratio:1.13
T/O Rate:1.80%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9300
EPS(LYR):-3.9545
ROE:-255.05%
ROA:-113.41%
PB:13.66
PE(LYR):-0.15

Loading ...

Sector Update: Healthcare Stocks Fall in Afternoon Trading

MT Newswires Live
·
Jun 02

BUZZ-U.S. STOCKS ON THE MOVE-Apple, JetBlue, Cognizant

Reuters
·
Jun 01

Jasper Therapeutics Explores Sale, Merger and Other Strategic Alternatives

MT Newswires Live
·
Jun 01

Jasper Therapeutics explores strategic alternatives, including asset sale or merger, to maximize shareholder value

Reuters
·
Jun 01

Jasper Therapeutics - Options Include Asset Sale, Licensing, Collaborations, Company Sale, Merger, or Wind-Down

THOMSON REUTERS
·
Jun 01

Jasper Therapeutics Announces Exploration of Strategic Alternatives to Maximize Shareholder Value

THOMSON REUTERS
·
Jun 01

Jasper Therapeutics Announces Board Resignation and Committee Change

TIPRANKS
·
May 22

Jasper Therapeutics director Christian Nolet resigns from board

Reuters
·
May 22

Jasper Therapeutics Is Maintained at Sector Perform by RBC Capital

Dow Jones
·
May 15

Jasper Therapeutics price target lowered to $3 from $4 at RBC Capital

TIPRANKS
·
May 15

TD Cowen Downgrades Jasper Therapeutics to Hold From Buy

MT Newswires Live
·
May 15

Jasper Therapeutics Inc : TD Cowen Cuts to Hold From Buy

THOMSON REUTERS
·
May 15

Jasper Therapeutics downgraded to Hold from Buy at TD Cowen

TIPRANKS
·
May 15

Jasper Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 15

Jasper Therapeutics Q1 net loss narrows 94% to $1.17 million

Reuters
·
May 15

Jasper Therapeutics Q1 Net Income USD -1.2 Million

THOMSON REUTERS
·
May 15

Jasper Therapeutics Q1 EPS USD -0.04

THOMSON REUTERS
·
May 15

Jasper Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update

GlobeNewswire
·
May 15

Jasper Therapeutics Inc expected to post a loss of 49 cents a share - Earnings Preview

Reuters
·
May 08